Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Genovefa D Kolovou; Dimitri P Mikhailidis; Jan Kovar; Dennis Lairon; Børge G Nordestgaard; Teik Chye Ooi; Pablo Perez-Martinez; Helen Bilianou; Katherine Anagnostopoulou; George Panotopoulos

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Genovefa D Kolovou, Dimitri P Mikhailidis, Jan Kovar, Dennis Lairon, Børge G Nordestgaard, Teik Chye Ooi, Pablo Perez-Martinez, Helen Bilianou, Katherine Anagnostopoulou, George Panotopoulos

236 Citationer (Scopus)

Abstract

An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is

Originalsprog	Engelsk
Tidsskrift	Current Vascular Pharmacology
Vol/bind	9
Udgave nummer	3
Sider (fra-til)	258-70
Antal sider	13
ISSN	1570-1611
Status	Udgivet - jun. 2011

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

@article{ad180a022e234108a2efec7b35886af4,

title = "Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement",

abstract = "An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is",

author = "Kolovou, {Genovefa D} and Mikhailidis, {Dimitri P} and Jan Kovar and Dennis Lairon and Nordestgaard, {B{\o}rge G} and Ooi, {Teik Chye} and Pablo Perez-Martinez and Helen Bilianou and Katherine Anagnostopoulou and George Panotopoulos",

year = "2011",

month = jun,

language = "English",

volume = "9",

pages = "258--70",

journal = "Current Vascular Pharmacology",

issn = "1570-1611",

publisher = "Bentham Science Publishers",

number = "3",

}

TY - JOUR

T1 - Assessment and clinical relevance of non-fasting and postprandial triglycerides

T2 - an expert panel statement

AU - Kolovou, Genovefa D

AU - Mikhailidis, Dimitri P

AU - Kovar, Jan

AU - Lairon, Dennis

AU - Nordestgaard, Børge G

AU - Ooi, Teik Chye

AU - Perez-Martinez, Pablo

AU - Bilianou, Helen

AU - Anagnostopoulou, Katherine

AU - Panotopoulos, George

PY - 2011/6

Y1 - 2011/6

N2 - An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is

AB - An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is

M3 - Journal article

SN - 1570-1611

VL - 9

SP - 258

EP - 270

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

IS - 3

ER -

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

Abstract

FN’s Verdensmål

Fingeraftryk

Citationsformater